Biotech Boulevard
Startups and Spinouts
GEN's Biotech Boulevard highlights new entrepreneurial biotech firms based all over the globe. These unique companies are developing breakthrough products that will expand and enhance the biotech industry.
Discover, invest, and collaborate with these industry leaders of tomorrow.
Explore Biotech Boulevard. It's paved with opportunities!
GEN's Biotech Boulevard
All  A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z   0  1  2  3  4  5  6  7  8  9   
  • XL-protein

    XL-protein is a privately owned German biotech company commercializing the PASylation technology, which allows the extension of the plasma half-life of biopharmaceuticals. XL-protein focuses on the preclinical and clinical development of PASylated proteins in several disease areas. Its goal is to provide improved second-generation biopharma­ceuticals allowing less frequent and lower dosing together with better tolerability, making treatment cheaper and supporting patient compliance and safety.

© 2012 Genetic Engineering & Biotechnology News. All Rights Reserved.
Back to